TWINJECT 0.15 Drug Patent Profile
✉ Email this page to a colleague
When do Twinject 0.15 patents expire, and when can generic versions of Twinject 0.15 launch?
Twinject 0.15 is a drug marketed by Impax and is included in one NDA.
The generic ingredient in TWINJECT 0.15 is epinephrine. There are twenty-one drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the epinephrine profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Twinject 0.15
A generic version of TWINJECT 0.15 was approved as epinephrine by BPI LABS on July 29th, 2014.
Summary for TWINJECT 0.15
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 5 |
Raw Ingredient (Bulk) Api Vendors: | 88 |
Clinical Trials: | 1 |
Patent Applications: | 3,981 |
Formulation / Manufacturing: | see details |
DailyMed Link: | TWINJECT 0.15 at DailyMed |
Recent Clinical Trials for TWINJECT 0.15
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
University of Louisville | Phase 4 |
Arthroplasty Foundation, Inc. | Phase 4 |
Anatomical Therapeutic Chemical (ATC) Classes for TWINJECT 0.15
US Patents and Regulatory Information for TWINJECT 0.15
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Impax | TWINJECT 0.15 | epinephrine | INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS | 020800-002 | May 28, 2004 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for TWINJECT 0.15
See the table below for patents covering TWINJECT 0.15 around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
World Intellectual Property Organization (WIPO) | 2012103130 | ⤷ Try a Trial | |
Canada | 2163005 | SYSTEME D'INJECTION D'URGENCE, RECHARGEABLE, AUTOMATIQUE OU MANUEL (RELOADABLE AUTOMATIC OR MANUAL EMERGENCY INJECTION SYSTEM) | ⤷ Try a Trial |
Norway | 20080672 | ⤷ Try a Trial | |
Denmark | 2320973 | ⤷ Try a Trial | |
European Patent Office | 2320973 | ENSEMBLE AIGUILLE D'INJECTION (INJECTION NEEDLE ASSEMBLY) | ⤷ Try a Trial |
European Patent Office | 3263161 | ENSEMBLE AIGUILLE D'INJECTION (INJECTION NEEDLE ASSEMBLY) | ⤷ Try a Trial |
Taiwan | 200727928 | Method and apparatus for delivering epinephrine | ⤷ Try a Trial |
>Country | >Patent Number | >Title | >Estimated Expiration |